
About Naturespired
Naturespired is a publicly listed company based in Zirakpur (India) founded in 2021. Zimbra provides web client for email, messaging, and collaboration features online. It operates on a SaaS model. The company has 3,550 employees. Its Indian entity Jeena Sikho Lifecare Limited reported revenue of ₹810 Cr. Naturespired offers products and services including Zimbra Web Client. Its focus areas include Information Technology, Collaboration Software, Messaging Platforms and Web Clients. Its competitors include Mamaearth, WOW Skin Science and Juicy Chemistry; 3 of its 3 listed competitors have raised funding.
Company details
Zimbra is a web client developed by Synacor, Inc., focusing on open source messaging and collaboration tools. It includes versions like advanced, standard, and mobile to support various internet speeds and devices. Users access features such as email, calendars, and productivity tools through a sign-in interface. The platform promotes community engagement via blogs, wikis, and forums, emphasizing accessibility and efficiency in digital communication.
- Headquarters Zirakpur, India
- Employees 3,550
- Stage Public
- SectorsTechnology
- Website naturespired.com
- Social Facebook
- Legal Name Jeena Sikho Lifecare Limited
- Date of Incorporation 29 May, 2017
- Jurisdiction Zirakpur, Punjab, India
- Market Cap₹3,729 Cr
JSLL · NSE
- Share Price₹296.35
-1.20% today
- Revenue₹801 Cr
FY 2025-26
- EBITDA₹349 Cr
Margin 43.6%
- Net Profit₹222 Cr
FY 2025-26
- P/E (TTM)18.0x
P/B 7.5x
- ROE61.3%
ROCE 63.7%
- Debt / Equity0.34
Interest cover 4.6x
- Employee Count3,550
Associated legal entities of Naturespired
Naturespired operates through Jeena Sikho Lifecare Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Jeena Sikho Lifecare Limited Listed CIN L52601PB2017PLC046545 | Active | 29 May 2017 | Zirakpur, Punjab | ₹810 Cr | 1,541 | 12 | View details |
Products & Services of Naturespired
Naturespired offers a comprehensive portfolio of products and services, including Zimbra Web Client.
Web-based platform for email, messaging, and productivity features.
Board of directors of Jeena Sikho Lifecare Limited (Naturespired)
Jeena Sikho Lifecare Limited is the primary company behind Naturespired. The board of Jeena Sikho Lifecare Limited currently have 10 directors; the longest-serving is Shreya Grover, appointed in 2021. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shreya Grover DIN 09199495 | Whole-time director | 12 Jun 2021 | 5 yrs 5 mo | Jeena Sikho Lifecare Limited |
| Karan Vir Bindra DIN 09283623 | Director | 25 Aug 2021 | 5 yrs 2 mo | Jeena Sikho Lifecare Limited |
| Manish Grover DIN 07557886 | Managing Director | 25 Aug 2021 | 5 yrs 2 mo | Jeena Sikho Lifecare Limited |
| Bhavna Grover DIN 07557913 | Whole-time director | 25 Aug 2021 | 5 yrs 2 mo | Jeena Sikho Lifecare Limited |
| Chandan Kumar Kaushal DIN 10515819 | Director | 29 Apr 2024 | 2 yrs 6 mo | Jeena Sikho Lifecare Limited |
| Priyanka Bansal DIN 09051665 | Director | 21 Apr 2025 | 1 yr 6 mo | Jeena Sikho Lifecare Limited |
| Ankush Kaushal DIN 03308862 | Whole-time director | 15 Jul 2026 | 4 mo | Jeena Sikho Lifecare Limited |
| Ajay Sharma DIN 07671350 | Director | 15 Jul 2026 | 4 mo | Jeena Sikho Lifecare Limited |
| Sapna Singh DIN 11812894 | Director | 15 Jul 2026 | 4 mo | Jeena Sikho Lifecare Limited |
| Ish Sharma DIN 11815526 | Whole-time director | 15 Jul 2026 | 4 mo | Jeena Sikho Lifecare Limited |
IPO & Listings of Naturespired
Naturespired is a publicly listed company on the NSE with ticker symbol JSLL in India, operating in the Pharmaceuticals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: JSLL
- Listed entityJeena Sikho Lifecare Limited
- Exchange sectorPharmaceuticals
Financials of Naturespired
Exchange-reported figures of Jeena Sikho Lifecare Limited, the listed company behind Naturespired (NSE: JSLL).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Income statement | |||
| Revenue | 801 | 205 | 147 |
| Revenue growth | - | +39.7% | - |
| EBITDA | 349 | 45.85 | 18.09 |
| EBITDA margin | +43.6% | +22.4% | +12.3% |
| Profit before tax | 297 | 44.30 | 15.09 |
| Net profit | 222 | 33.39 | 10.65 |
| Net profit margin | +27.7% | +16.3% | +7.3% |
| EPS (₹) | 17.81 | 24.46 | 11.11 |
| Balance sheet | |||
| Total assets | 601 | 127 | 44.00 |
| Net worth | 467 | 126 | 36.51 |
| Total debt | 127 | 0.81 | 7.43 |
| Cash & bank | 109 | 32.39 | 2.59 |
| Net working capital | 172 | 48.59 | 4.26 |
| Cash flow | |||
| Cash from operations | 254 | 14.52 | 16.35 |
| Cash from investing | (202) | (33.10) | (18.49) |
| Cash from financing | (58.68) | 48.00 | (4.51) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 235 | 224 | 216 | 222 | 190 | 174 | 139 | 116 |
| Revenue growth (YoY) | +23.9% | +28.8% | +54.8% | +91.6% | +66.4% | +74.2% | - | - |
| Other income | (1.94) | 14.33 | 3.42 | 2.57 | 1.44 | 1.07 | 0.27 | 0.39 |
| EBITDA | 71.99 | 92.06 | 77.92 | 101 | 92.03 | 78.76 | 45.77 | 29.61 |
| EBITDA margin | +30.6% | +41.0% | +36.1% | +45.4% | +48.5% | +45.2% | +32.9% | +25.6% |
| Depreciation | 16.49 | 15.39 | 16.38 | 11.26 | 10.40 | 9.65 | 9.03 | 8.47 |
| Interest | 4.04 | 3.47 | 3.73 | 3.10 | 4.35 | 1.66 | 3.10 | 3.79 |
| Profit before tax | 49.52 | 87.53 | 61.23 | 88.93 | 78.72 | 68.52 | 33.91 | 17.74 |
| Tax | 12.90 | 21.64 | 16.14 | 22.33 | 19.97 | 17.24 | 8.58 | 4.53 |
| Net profit | 36.62 | 65.89 | 45.09 | 66.60 | 58.75 | 51.28 | 25.33 | 13.21 |
| EPS (₹) | 2.94 | 5.29 | 3.62 | 5.35 | 4.72 | 4.12 | 2.04 | 1.06 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 801 | 469 | 324 | 204 | 146 | 136 | 94.42 |
| Revenue growth | +70.8% | +44.6% | +59.1% | +39.2% | +7.8% | +43.8% | - |
| EBITDA | 350 | 125 | 93.01 | 46.32 | 18.16 | 16.96 | 10.55 |
| EBITDA margin | +43.6% | +26.7% | +28.7% | +22.7% | +12.4% | +12.5% | +11.2% |
| Profit before tax | 298 | 122 | 93.92 | 44.52 | 15.16 | 14.21 | 7.73 |
| Net profit | 222 | 88.25 | 67.87 | 33.34 | 10.68 | 10.42 | 5.74 |
| Net profit margin | +27.7% | +18.8% | +20.9% | +16.4% | +7.3% | +7.7% | +6.1% |
| EPS (₹) | 17.85 | 36.50 | 27.84 | 24.43 | 11.15 | 1,015.21 | 572.63 |
| Balance sheet | |||||||
| Total assets | 601 | 377 | 193 | 127 | 44.07 | 36.46 | 26.41 |
| Net worth | 467 | 256 | 192 | 126 | 36.55 | 23.95 | 13.73 |
| Total debt | 127 | 117 | 0.54 | 0.81 | 7.43 | 12.03 | 12.46 |
| Cash & bank | 108 | 22.98 | 62.01 | 32.39 | 2.57 | 8.96 | 1.44 |
| Net working capital | 163 | 90.09 | 114 | 48.59 | 4.83 | 13.70 | 9.46 |
| Cash flow | |||||||
| Cash from operations | 262 | 84.50 | 36.69 | 17.17 | 17.48 | 17.53 | 11.74 |
| Cash from investing | (211) | (64.38) | (18.05) | (57.23) | (19.64) | (8.47) | (5.97) |
| Cash from financing | (58.73) | (22.45) | (3.44) | 48.00 | (4.51) | (1.53) | (5.05) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 235 | 224 | 216 | 222 | 190 | 174 | 139 | 116 |
| Revenue growth (YoY) | +23.9% | +28.8% | +54.8% | +91.6% | +66.4% | +74.2% | - | - |
| Other income | (2.31) | 14.02 | 3.58 | 2.57 | 1.44 | 1.07 | 0.27 | 0.39 |
| Total expenses | 163 | 132 | 138 | 121 | 97.78 | 95.50 | 93.48 | 86.08 |
| EBITDA | 72.03 | 92.12 | 77.98 | 101 | 92.07 | 78.79 | 45.77 | 29.61 |
| EBITDA margin | +30.6% | +41.1% | +36.2% | +45.5% | +48.5% | +45.2% | +32.9% | +25.6% |
| Depreciation | 16.43 | 15.33 | 16.32 | 11.21 | 10.40 | 9.65 | 9.03 | 8.47 |
| Interest | 4.04 | 3.47 | 3.73 | 3.10 | 4.35 | 1.66 | 3.10 | 3.79 |
| Profit before tax | 49.25 | 87.34 | 61.51 | 89.05 | 78.76 | 68.55 | 33.91 | 17.74 |
| Tax | 12.91 | 21.65 | 16.15 | 22.33 | 19.97 | 17.24 | 8.58 | 4.53 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 235 | 224 | 216 | 222 | 190 | 174 | 139 | 116 |
| Revenue growth (YoY) | +23.9% | +28.8% | +54.8% | +91.6% | +66.4% | +74.2% | - | - |
| Other income | (1.94) | 14.33 | 3.42 | 2.57 | 1.44 | 1.07 | 0.27 | 0.39 |
| EBITDA | 71.99 | 92.06 | 77.92 | 101 | 92.03 | 78.76 | 45.77 | 29.61 |
| EBITDA margin | +30.6% | +41.0% | +36.1% | +45.4% | +48.5% | +45.2% | +32.9% | +25.6% |
| Depreciation | 16.49 | 15.39 | 16.38 | 11.26 | 10.40 | 9.65 | 9.03 | 8.47 |
| Interest | 4.04 | 3.47 | 3.73 | 3.10 | 4.35 | 1.66 | 3.10 | 3.79 |
| Profit before tax | 49.52 | 87.53 | 61.23 | 88.93 | 78.72 | 68.52 | 33.91 | 17.74 |
| Tax | 12.90 | 21.64 | 16.14 | 22.33 | 19.97 | 17.24 | 8.58 | 4.53 |
| Net profit | 36.62 | 65.89 | 45.09 | 66.60 | 58.75 | 51.28 | 25.33 | 13.21 |
| EPS (₹) | 2.94 | 5.29 | 3.62 | 5.35 | 4.72 | 4.12 | 2.04 | 1.06 |
| Particulars | FY 2025-26 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Revenue | 801 | 205 | 147 |
| Revenue growth | - | +39.7% | - |
| Other income | 8.50 | 2.60 | 1.49 |
| Total expenses | 452 | 159 | 128 |
| Employee cost | 0.00 | 44.05 | 33.80 |
| EBITDA | 349 | 45.85 | 18.09 |
| EBITDA margin | +43.6% | +22.4% | +12.3% |
| Depreciation | 47.69 | 3.20 | 3.31 |
| Interest | 12.83 | 0.95 | 1.18 |
| Profit before tax | 297 | 44.30 | 15.09 |
| Tax | 75.69 | 10.77 | 3.89 |
| Net profit | 222 | 33.39 | 10.65 |
| Net profit margin | +27.7% | +16.3% | +7.3% |
| EPS (₹) | 17.81 | 24.46 | 11.11 |
| Particulars | FY 2025-26 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Equity & liabilities | |||
| Share capital | 24.86 | 13.81 | 10.11 |
| Reserves & surplus | 442 | 112 | 26.40 |
| Shareholders' funds (net worth) | 467 | 126 | 36.51 |
| Minority interest | (0.13) | 0.00 | (0.03) |
| Secured loans | 0.43 | 0.81 | 1.08 |
| Unsecured loans | 127 | 0.00 | 6.35 |
| Total debt | 127 | 0.81 | 7.43 |
| Total liabilities | 601 | 127 | 44.00 |
| Assets | |||
| Gross block | 384 | 70.76 | 36.84 |
| Net block | 293 | 59.74 | 28.59 |
| Capital work in progress | 2.86 | 1.13 | 5.04 |
| Investments | 110 | 4.55 | 0.00 |
| Inventories | 20.22 | 4.10 | 6.36 |
| Sundry debtors | 69.93 | 22.07 | 9.04 |
| Cash & bank balances | 109 | 32.39 | 2.59 |
| Loans & advances | 46.78 | 14.36 | 3.53 |
| Total current assets | 246 | 72.92 | 21.52 |
| Total current liabilities | 73.43 | 24.33 | 17.26 |
| Net working capital | 172 | 48.59 | 4.26 |
| Total assets | 601 | 127 | 44.00 |
| Particulars | FY 2025-26 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Opening cash | 22.98 | 2.19 | 8.84 |
| Net cash from operating activities | 254 | 14.52 | 16.35 |
| Net cash from investing activities | (202) | (33.10) | (18.49) |
| Net cash from financing activities | (58.68) | 48.00 | (4.51) |
| Net change in cash | (6.61) | 29.42 | (6.65) |
| Closing cash | 109 | 32.39 | 2.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | - | +129.1% | +39.7% | - |
| EBITDA growth | - | +206.7% | +153.5% | - |
| PBT growth | +176.5% | +142.8% | +193.6% | +9997.0% |
| Net income growth | - | +132.4% | +213.5% | - |
| Revenue CAGR (3Y) | +76.2% | - | - | - |
| EBITDA CAGR (3Y) | +168.6% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +27.7% | +17.0% | +16.4% | +7.6% |
| Return on capital employed | +63.7% | +31.4% | +53.0% | +37.0% |
| Return on net worth | +61.3% | +31.2% | +41.3% | +30.7% |
| Debt / equity | 0.34 | 0.46 | 0.05 | 0.20 |
| Long-term debt / equity | 0.25 | 0.33 | 0.01 | 0.02 |
| Interest cover | 4.58 | 9.55 | 2.23 | 7.98 |
| Efficiency & per share | ||||
| Fixed asset turnover | 2.35 | 1.58 | 3.81 | 3.98 |
| Inventory turnover | 50.45 | 40.61 | 39.15 | 23.04 |
| Debtors turnover | 10.35 | 5.52 | 13.16 | 16.21 |
| EPS (₹) | 17.84 | 32.16 | 24.46 | 11.11 |
| Dividend per share (₹) | 4.50 | 5.47 | 2.00 | 0.00 |
| Book value per share (₹) | 37.58 | 103.11 | 91.09 | 36.11 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 235 | 224 | 216 | 222 | 190 | 174 | 139 | 116 |
| Revenue growth (YoY) | +23.9% | +28.8% | +54.8% | +91.6% | +66.4% | +74.2% | - | - |
| Other income | (2.31) | 14.02 | 3.58 | 2.57 | 1.44 | 1.07 | 0.27 | 0.39 |
| Total expenses | 163 | 132 | 138 | 121 | 97.78 | 95.50 | 93.48 | 86.08 |
| EBITDA | 72.03 | 92.12 | 77.98 | 101 | 92.07 | 78.79 | 45.77 | 29.61 |
| EBITDA margin | +30.6% | +41.1% | +36.2% | +45.5% | +48.5% | +45.2% | +32.9% | +25.6% |
| Depreciation | 16.43 | 15.33 | 16.32 | 11.21 | 10.40 | 9.65 | 9.03 | 8.47 |
| Interest | 4.04 | 3.47 | 3.73 | 3.10 | 4.35 | 1.66 | 3.10 | 3.79 |
| Profit before tax | 49.25 | 87.34 | 61.51 | 89.05 | 78.76 | 68.55 | 33.91 | 17.74 |
| Tax | 12.91 | 21.65 | 16.15 | 22.33 | 19.97 | 17.24 | 8.58 | 4.53 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 801 | 469 | 324 | 204 | 146 | 136 | 94.42 |
| Revenue growth | +70.8% | +44.6% | +59.1% | +39.2% | +7.8% | +43.8% | - |
| Other income | 8.66 | 6.41 | 6.44 | 2.28 | 1.49 | 1.07 | 0.76 |
| Total expenses | 452 | 344 | 231 | 158 | 128 | 119 | 83.87 |
| Employee cost | 0.00 | 100 | 65.91 | 43.44 | 33.75 | 30.38 | 21.65 |
| EBITDA | 350 | 125 | 93.01 | 46.32 | 18.16 | 16.96 | 10.55 |
| EBITDA margin | +43.6% | +26.7% | +28.7% | +22.7% | +12.4% | +12.5% | +11.2% |
| Depreciation | 47.58 | 8.71 | 5.10 | 3.13 | 3.31 | 2.46 | 1.94 |
| Interest | 12.83 | 0.97 | 0.43 | 0.95 | 1.18 | 1.36 | 1.64 |
| Profit before tax | 298 | 122 | 93.92 | 44.52 | 15.16 | 14.21 | 7.73 |
| Tax | 75.70 | 31.34 | 24.71 | 10.78 | 3.89 | 3.89 | 1.99 |
| Net profit | 222 | 88.25 | 67.87 | 33.34 | 10.68 | 10.42 | 5.74 |
| Net profit margin | +27.7% | +18.8% | +20.9% | +16.4% | +7.3% | +7.7% | +6.1% |
| EPS (₹) | 17.85 | 36.50 | 27.84 | 24.43 | 11.15 | 1,015.21 | 572.63 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 24.86 | 24.86 | 24.86 | 13.81 | 10.11 | 0.10 | 0.10 |
| Reserves & surplus | 443 | 231 | 167 | 112 | 26.44 | 23.85 | 13.63 |
| Shareholders' funds (net worth) | 467 | 256 | 192 | 126 | 36.55 | 23.95 | 13.73 |
| Secured loans | 0.43 | 0.74 | 0.54 | 0.81 | 1.08 | 0.23 | 0.66 |
| Unsecured loans | 127 | 116 | 0.00 | 0.00 | 6.35 | 11.80 | 11.80 |
| Total debt | 127 | 117 | 0.54 | 0.81 | 7.43 | 12.03 | 12.46 |
| Total liabilities | 601 | 377 | 193 | 127 | 44.07 | 36.46 | 26.41 |
| Assets | |||||||
| Gross block | 383 | 298 | 82.38 | 70.76 | 36.59 | 28.33 | 19.98 |
| Net block | 292 | 253 | 66.85 | 59.74 | 28.34 | 22.68 | 16.66 |
| Capital work in progress | 2.71 | 13.48 | 3.94 | 1.13 | 5.04 | 0.00 | 0.00 |
| Investments | 110 | 3.56 | 4.14 | 4.55 | 0.01 | 0.00 | 0.00 |
| Inventories | 20.17 | 11.55 | 7.19 | 4.10 | 5.76 | 9.28 | 10.56 |
| Sundry debtors | 69.93 | 84.96 | 41.19 | 22.07 | 8.97 | 3.24 | 4.38 |
| Cash & bank balances | 108 | 22.98 | 62.01 | 32.39 | 2.57 | 8.96 | 1.44 |
| Loans & advances | 37.50 | 12.58 | 30.46 | 14.36 | 4.74 | 4.61 | 4.54 |
| Total current assets | 235 | 132 | 141 | 72.92 | 22.04 | 26.09 | 20.92 |
| Total current liabilities | 71.89 | 41.98 | 27.19 | 24.33 | 17.21 | 12.39 | 11.46 |
| Net working capital | 163 | 90.09 | 114 | 48.59 | 4.83 | 13.70 | 9.46 |
| Total assets | 601 | 377 | 193 | 127 | 44.07 | 36.46 | 26.41 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 22.98 | 25.31 | 10.12 | 2.17 | 8.84 | 1.44 | 0.71 |
| Net cash from operating activities | 262 | 84.50 | 36.69 | 17.17 | 17.48 | 17.53 | 11.74 |
| Net cash from investing activities | (211) | (64.38) | (18.05) | (57.23) | (19.64) | (8.47) | (5.97) |
| Net cash from financing activities | (58.73) | (22.45) | (3.44) | 48.00 | (4.51) | (1.53) | (5.05) |
| Net change in cash | (7.82) | (2.34) | 15.20 | 7.94 | (6.67) | 7.53 | 0.73 |
| Closing cash | 108 | 22.98 | 62.01 | 32.39 | 2.57 | 8.96 | 1.44 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +70.8% | +44.6% | +59.1% | +39.2% | +7.8% | +43.8% | - |
| EBITDA growth | +179.0% | +34.8% | +100.8% | +155.1% | +7.1% | +60.8% | - |
| PBT growth | +176.9% | +14.5% | +111.0% | +193.7% | +6.7% | +83.8% | -7.1% |
| Net income growth | +151.8% | +30.0% | +103.6% | +212.2% | +2.5% | +81.5% | - |
| Revenue CAGR (3Y) | +57.8% | +47.4% | +33.7% | +29.3% | +11.4% | - | - |
| EBITDA CAGR (3Y) | +96.4% | +97.8% | +76.4% | +63.8% | +19.6% | - | - |
| Profitability & leverage | |||||||
| Net income margin | +27.7% | +17.0% | +21.3% | +16.6% | +7.7% | +7.6% | +6.1% |
| Return on capital employed | +63.7% | +41.5% | +59.0% | +53.3% | +40.6% | +49.4% | +37.4% |
| Return on net worth | +61.4% | +35.6% | +43.5% | +41.6% | +37.3% | +54.6% | +52.7% |
| Debt / equity | 0.34 | 0.26 | 0.00 | 0.05 | 0.32 | 0.65 | 1.29 |
| Long-term debt / equity | 0.25 | 0.19 | 0.00 | 0.01 | 0.02 | 0.02 | 0.05 |
| Interest cover | 4.58 | 9.55 | 0.49 | 2.20 | 7.95 | 9.38 | 19.05 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.35 | 2.47 | 4.24 | 3.80 | 4.51 | 5.62 | 5.55 |
| Inventory turnover | 50.53 | 50.06 | 57.47 | 41.36 | 19.47 | 13.69 | 8.13 |
| Debtors turnover | 10.35 | 7.44 | 10.26 | 13.14 | 23.99 | 35.65 | 22.01 |
| EPS (₹) | 17.87 | 32.16 | 27.84 | 24.43 | 11.15 | 1,015.21 | 572.63 |
| Dividend per share (₹) | 4.50 | 5.47 | 4.80 | 2.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 37.60 | 103.11 | 77.33 | 91.09 | 36.15 | 2,362.31 | 1,372.83 |
Competitors of Naturespired
Naturespired has 3 listed competitors in our database, 3 of them funded. They include Mamaearth, WOW Skin Science and Juicy Chemistry.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mamaearth.in | 2016 | Gurugram, India | $89.36M | 1,900 | Online brand offering multi-category natural skin care and makeup products | |
| buywow.in | 2014 | Bengaluru, India | $98M | 100 | Organic beauty products are offered by an internet-first brand. | |
| juicychemistry.com | 2014 | Coimbatore, India | $7.56M | 52 | Natural skin and hair care products are sold online. |
Detailed competitors of Naturespired
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Naturespired
Complete news archive for Naturespired
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naturespired
Naturespired was founded in 2021.
Naturespired is headquartered in Zirakpur, India. It is registered at Zirakpur, Punjab, India.
Naturespired has 3,550 employees.
The primary company behind Naturespired, Jeena Sikho Lifecare Limited, reported revenue of ₹810 Cr for FY 2026, up 291% year on year.
Zimbra is a web client developed by Synacor, Inc., focusing on open source messaging and collaboration tools. It includes versions like advanced, standard, and mobile to support various internet speeds and devices. Users access features such as email, calendars, and productivity tools through a sign-in interface. The platform promotes community engagement via blogs, wikis, and forums, emphasizing accessibility and efficiency in digital communication.
Naturespired's top competitors include Mamaearth, WOW Skin Science and Juicy Chemistry.
Naturespired offers Zimbra Web Client.
Yes, Naturespired is publicly traded on NSE under the ticker symbol JSLL.
Naturespired operates through Jeena Sikho Lifecare Limited.
The legal entities of Naturespired currently have 12 directors, including Karan Vir Bindra, Manish Grover, Shreya Grover and others.
